Navigation Links
Bioethics Commission calls for enhanced federal oversight in new field of synthetic biology
Date:12/16/2010

Washington, DC The Presidential Commission for the Study of Bioethical Issues today released its first reporta wide-ranging review of the emerging field of synthetic biologyissuing 18 recommendations including a call for coordinated federal oversight of scientists working in both large institutions and smaller settings.

The panel, comprised of 13 scientists, ethicists, and public policy experts, said that the very newness of the science, which involves the design and construction of laboratory-made biological parts, gives regulators, ethicists and others time to identify any problems early on and craft solutions that can harness the technology for the public good.

"We comprehensively reviewed the developing field of synthetic biology to understand both its potential rewards and risks," said Dr. Amy Gutmann, the Commission Chair and President of the University of Pennsylvania. "We considered an array of approaches to regulationfrom allowing unfettered freedom with minimal oversight and another to prohibiting experiments until they can be ruled completely safe beyond a reasonable doubt. We chose a middle course to maximize public benefits while also safeguarding against risks."

Dr. Gutmann said the Commission's approach recognizes the great potential of synthetic biology, including life saving medicines, and the still distant risks posed by the field. "Prudent vigilance suggests that federal oversight is needed and can be exercised in a way that is consistent with scientific progress," she said.

President Obama asked the Commission to study the implications of synthetic biology following the May 20 announcement by the J. Craig Venter Institute that it had inserted a laboratory-made genome into a bacterial cell, creating an organism not found in nature. In three public hearings held over the past five months in Washington, D.C., Philadelphia, and Atlanta, the Commission heard from over three-dozen ethicists, scientists and others close to the issue and considered a range of possible actions the government could take to prevent problems that might occur in the future.

Several experts explored potential benefits of synthetic biology, including the development of vaccines and new drugs and the production of biofuels that could someday reduce the need for fossil fuels. Discussions addressed the risks posed by the technology, including the inadvertent release of a laboratory-created organism into nature and the potential adverse effects of such a release on ecosystems. To reduce any possible threat, some scientists and ethicists advised careful monitoring and review of the research.

The Commission concluded that while the technical challenges of synthetic biology remain daunting, the field is likely to become more decentralized as the relevant tools become increasingly available and affordable-a change that may pose novel challenges with regard to oversight

"While the 'Do-It-Yourself' community has an important role to play in advancing synthetic biology, we recognize that technical challenges and costs are too high right now for a completely novel organism to be developed in a non-institutional setting," said Dr. James W. Wagner, Commission Vice Chair and President of Emory University. "We strongly support an open dialogue between DIY groups and the government as we go forward so that scientists and government can discuss the research constraints necessary to protect public safety as the field continues to evolve."

The Commission recommended the following steps in order to minimize risks and to foster innovation:

  • The Executive Office of the President, possibly through the Office of Science and Technology Policy, should coordinate federal agencies that oversee areas related to synthetic biology, including oversight, product licensing and funding.

  • Risk assessment activities across the government need to be coordinated and field release permitted only after reasonable risk assessment.

  • The Executive Office of the President should remain actively engaged with "do it yourself" groups to communicate and discuss applicable safety and security issues.

  • Recognizing that international coordination is essential for safety and security, the Department of State, in concert with the Department of Health and Human Services and the Department of Homeland Security, should collaborate with governments around the world, as well as leading international organizations, such as the World Health Organization to promote ongoing dialogue about emerging technologies like synthetic biology.

  • The National Institutes of Health, the Department of Energy and other federal agencies should evaluate research proposals through peer-review in order to make sure that the most promising scientific research is conducted on the public's behalf.

  • Educational classes on the ethical dilemmas raised by synthetic biology should be a mandatory part of training for young researchers, engineers, and others who work in this emerging field.

  • Forums should be established to improve the general public's understanding of this field, including the creation of a biology equivalent to FactCheck.org, in which a private group would track statements about the science and offer an independent view of the truth of such claims.

Dr. Gutmann noted that the issues considered are relevant well beyond government officials and emphasized the value of informed public conversation regarding scientific research.

"The public, journalists, and policymakers need facts and reliable analyses to help them understand the benefits as well as the risks of new technologies," said Gutmann. "To aid public understanding of emerging scientific issues, the Commission is recommending that an independent organization do for synthetic biology and biotechnology what factcheck.org does for politicsbe an online resource to check the truthfulness of prominent claims and criticisms about new scientific discoveries and help spur informed discussion."


'/>"/>

Contact: Jemma Weymouth
jweymouth@burnesscommunications.com
301-652-1558
Burness Communications
Source:Eurekalert

Related biology news :

1. Overcoming Taboos, Myths, and Dogmas in Bioethics
2. March of Dimes establishes 2 new perinatal bioethics awards
3. Bioethics beach reading, Summer 2010 edition
4. 4 essays look at the next generation of bioethics
5. NOAA and NSF commission national study of ocean acidification
6. North American environmental commission launches trinational vaquita conservation plan
7. Tuna Commission to decide the future of Mediterranean bluefin
8. End of the line for Tuna Commission
9. Another fisheries commission throws the science overboard in tuna decision, WWF says
10. CWRU receives $5 million from Ohio Third Frontier Commission
11. Statement of ESHRE on the European Commission proposal of viral screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Vigilant Solutions , a vehicle location ... announced today the appointment of retired FBI special agent ... business development. Mr. Sheridan brings more than ... focus on the aviation transportation sector, to his new ... Sheridan served as the Aviation Liaison Agent Coordinator (ALAC) ...
(Date:3/16/2017)... - Against identity fraud with DERMALOG solutions "Made in Germany "  ... ... multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity ... ...
(Date:3/9/2017)... VIEW, Calif. , March 9, 2017 ... 23andMe , the leading personal genetics company, are using ... now provide customers with personalized nutrition plans that consider ... but also genetic markers impacting how their body may ... food decision support platform uses biometrics such as Body ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... ... March 28, 2017 , ... ... development of a new orally administered treatment for Alzheimer’s disease (AD), today announced ... Didsbury states, “As we seek to uniquely treat the metabolic dysfunctions inherent in ...
(Date:3/27/2017)... ... March 27, 2017 , ... Biopsies from non-small cell ... with limited tumor content in a large background of normal or wild type ... need for reliable detection of low abundance somatic mutations, particularly in small specimens ...
(Date:3/27/2017)... ... ... PMG Research is pleased to announce its participation in the 2nd ... Boston on April 3-4, 2017. The CTC conference focuses on how the industry is ... closer to the patient. Clinical Trial Collaborations also will present an inaugural conference on ...
(Date:3/24/2017)... 2017 MiMedx Group, Inc. (NASDAQ: MDXG), the ... tissue allografts and patent-protected processes to develop and market ... announced today  that it will present at the Needham ... NY.  Parker H. "Pete" Petit, Chairman and CEO, ... M. Cashman , EVP and Chief Commercialization Officer, and ...
Breaking Biology Technology: